BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2024 3:11:19 PM | Browse: 187 | Download: 691
 |
Received |
|
2024-03-24 13:51 |
|
Peer-Review Started |
|
2024-03-24 13:51 |
|
First Decision by Editorial Office Director |
|
2024-05-08 03:06 |
|
Return for Revision |
|
2024-05-08 03:06 |
|
Revised |
|
2024-05-20 05:32 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-06-17 02:42 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-06-17 07:19 |
|
Articles in Press |
|
2024-06-17 07:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-07-28 13:31 |
|
Publish the Manuscript Online |
|
2024-08-27 15:11 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Biochemical Research Methods |
| Manuscript Type |
Editorial |
| Article Title |
MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ashraf Al Madhoun |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Kuwait Foundation for the Advancement of Sciences and Dasman Diabetes Institute, Kuwait |
RACB-2021-007 |
|
| Corresponding Author |
Ashraf Al Madhoun, PhD, Academic Research, Senior Scientist, Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Jassim AlBahar Street, Dasman 15400, Kuwait. ashraf.madhoun@dasmainstitute.org |
| Key Words |
Diabetic kidney disease; MicroRNA; MicroRNA-630; Toll-like receptor 4; Inflammation |
| Core Tip |
Wu et al identified microRNA-630 as a promising candidate for the management of diabetic kidney disease, exerting its protective effects through the regulation of toll-like receptor 4-mediated inflammatory pathways. Further research elucidating the precise molecular mechanisms underlying microRNA-630’s actions and its therapeutic potential is warranted, with the ultimate goal of developing targeted interventions to alleviate the burden of diabetic kidney disease and improve patient outcomes. |
| Publish Date |
2024-08-27 15:11 |
| Citation |
Al Madhoun A. MicroRNA-630: A potential guardian against inflammation in diabetic kidney disease. World J Diabetes 2024; 15(9): 1837-1841 |
| URL |
https://www.wjgnet.com/1948-9358/full/v15/i9/1837.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v15.i9.1837 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
